To meet the US Food and Drug Administration's (FDA) recommendation that manufacturers 'integrate a dose counting device into the development of their MDI drug product', Bespak has developed a dose counter that counts in single unit decrements and employs a design that minimises any risk of undercounting (and the potential to suggest to the user that doses remain in an empty pack) and has excellent overall count accuracy.
Bespak's BK640 dose counter offers minimal airflow resistance and is comparable to many 'conventional' marketed press & breath pMDIs, incorporates a removable mouthpiece for cleaning, has safety features that allow the device to continue to operate in the event of accidental breakage and yet represents good value with a design that is suitable for high-volume manufacture. The BK640 can be tailored to suit a range of canister sizes and to meet the marketing objectives for a development partner's programme.
Bespak has two designs, one developed in-house and the AsmairŪ device licensed through a partnership with Bang & Olufsen Medicom.